Status: Not yet recruiting
CTO-PCI in Heart Failure Patients
The study investigates wheather CTO-PCI improves survival and heart failure related rehospitalization compared to optimal medical therapy (OMT). This hypothesis will be investigated within a large-scaled international, representative, prospective, randomized, controlled, open-label, event-driven, multicentre trial (trial acronym: CTO - Heart Failure) recruiting patients with planned CTO-PCI.
Participants needed: 783
Trial details
Age: 18-90Biological sex: AllType: InterventionalSponsor: Universitätsmedizin MannheimUpdated: Sep 19, 2024
Eligibility criteria
Written informed consent. [+7]
Age <18 and >90 years. [+11]